Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in rats

European Journal of Pharmacology

Volumn 518, Issue 2-3, 2005, Pages 243-250

  Iwase, Masanori ^a   Nakamura, Udai ^a   Uchizono, Yuji ^a   Nohara, Sakae ^a   Sasaki, Nobuhiro ^a   Sonoki, Kazuo ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Microsphere; Nitric oxide; Oral hypoglycemic agent; Otsuka Long Evans Tokushima Fatty rat; Regional blood flow; Tolbutamide

Indexed keywords

3 METHYLGLUCOSE; N(G) METHYLARGININE; NATEGLINIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RAT STRAIN;

3-O-METHYLGLUCOSE; ADMINISTRATION, ORAL; ANESTHESIA; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CONSCIOUSNESS; CYCLOHEXANES; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; GASTROINTESTINAL TRACT; GLUCOSE; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; INSULIN; ISLETS OF LANGERHANS; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PHENYLALANINE; RATS; RATS, INBRED OLETF; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; TIME FACTORS; TOLBUTAMIDE;

EID: 23644449106     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.05.044     Document Type: Article

References (39)

1. N. Atef, B. Portha, and L. Penicaud Changes in islet blood flow in rats with NIDDM Diabetologia 37 1994 677 680
2. S. Bonner-Weir The microvasculature of the pancreas. With emphasis on that of the islets of Langerhans V.L. Go E.P. DiMagno The Pancreas: Biology, Pathobiology, and Disease 2nd ed. 1993 Raven Press New York 759 768
3. D. Bruttomesso, A. Pianta, A. Mari, A. Valerio, M.C. Marescotti, A. Avogaro, A. Tiengo, and S. Del Prato Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients Diabetes 48 1999 99 105
4. P.O. Carlsson, A. Andersson, and L. Jansson Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice Am. J. Physiol. 271 1996 E990 E995
5. P.O. Carlsson, S. Sandler, and L. Jansson Pancreatic islet blood perfusion in the nonobese diabetic mouse. Diabetes-prone female mice exhibit a higher blood flow compared with male mice in the prediabetic phase Endocrinology 139 1998 3534 3541
6. P.O. Carlsson, C. Berne, C.G. Östenson, A. Andersson, and L. Jansson Hypoglycaemia induces decreased islet blood perfusion mediated by the central nervous system in normal and Type 2 diabetic GK rats Diabetologia 46 2003 1124 1130
7. M.F. Carroll, A. Izard, K. Riboni, M.R. Burge, and D.S. Schade Control of postprandial hyperglycemia. Optimal use of short-acting insulin secretagogues Diabetes Care 25 2002 2147 2152
8. M. Chachin, M. Yamada, A. Fujita, T. Matsuoka, K. Matsushita, and Y. Kurachi Nateglinide, a d-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels J. Pharmacol. Exp. Ther. 304 2003 1025 1032
9. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
10. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A. Papapetropoulos, and W.C. Sessa Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
11. H. Hirose, H. Maruyama, Y. Seto, K. Ito, T. Fujita, K. Dan, N. Kanda, T. Saruta, and R. Kato Effects of d-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide Pharmacology 50 1995 175 181
12. S. Hu Interaction of nateglinide with KATP channel in beta-cells underlies its unique insulinotropic action Eur. J. Pharmacol. 442 2002 163 171
13. S. Hu, S. Wang, and B.E. Dunning Tissue selectivity of antidiabetic agent nateglinide. Study on cardiovascular and beta-cell K(ATP) channels J. Pharmacol. Exp. Ther. 291 1999 1372 1379
14. ATP channel activity and membrane-binding studies with nateglinide. A comparison with sulfonylureas and repaglinide J. Pharmacol. Exp. Ther. 293 2000 444 452
15. T. Ikenoue, M. Akiyoshi, S. Fujitani, K. Okazaki, N. Kondo, and T. Maki Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-d-phenylalanine (A-4166) Br. J. Pharmacol. 120 1997 137 145
16. N. Inagaki, T. Gonoi, J.P Clement IV, N. Namba, J. Inazawa, G. Gonzalez, L. Aguilar-Bryan, S. Seino, and J. Bryan Reconstitution of IKATP. An inward rectifier subunit plus the sulfonylurea receptor Science 270 1995 1166 1170
17. M. Iwase, S. Sandler, P.O. Carlsson, C. Hellerström, and L. Jansson The pancreatic islets in spontaneously hypertensive rats. Islet blood flow and insulin production Eur. J. Endocrinol. 144 2001 169 178
18. M. Iwase, K. Tashiro, Y. Uchizono, D. Goto, and M. Yoshinari Pancreatic islet blood flow in conscious rats during hyperglycemia and hypoglycemia Am. J. Physiol. 280 2001 R1601 R1605
19. M. Iwase, Y. Uchizono, K. Tashiro, D. Goto, and M. Iida Islet hyperperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes Diabetes 51 2002 2530 2535
20. L. Jansson The regulation of pancreatic islet blood flow Diabetes/Metab. Rev. 10 1994 407 416
21. L. Jansson Effects of the biguanide metformin on splanchnic blood flow in rats. Preferential and dose-dependent increase in islet blood flow Pharmacology 51 1995 43 47
22. L. Jansson, and C. Hellerström Stimulation by glucose of the blood flow to the pancreatic islets of the rat Diabetologia 25 1983 45 50
23. ATP channels and pancreatic islet blood flow in anesthetized rats. Increased blood flow induced by potassium channel openers Diabetes 52 2003 2043 2048
24. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain Diabetes 41 1992 1422 1428
25. N. Kobayashi, K. Kobayashi, K. Kouno, S. Horinaka, and S. Yagi Effects of intra-atrial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats Am. J. Physiol. 266 1994 H1910 H1917
26. A.D. Lajoix, H. Reggio, T. Chardes, S. Peraldi-Roux, F. Tribillac, M. Roye, S. Dietz, C. Broca, M. Manteghetti, G. Ribes, C.B. Wollheim, and R. Gross A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion Diabetes 50 2001 1311 1323
27. R. Moreau, H. Kirstetter, P. Yang, S. Aupetit-Faisant, B. Cailmail, S. Lebrec, and D. Lebrec Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats Br. J. Pharmacol. 112 1994 649 653
28. M. Okamoto, N. Ogihara, W. Kawamura, S. Ebihara, K. Takiguchi, T. Morita, R. Uchida, J. Yamaguchi, T. Sakai, Y. Okuda, Y. Hayashi, Y. Arakawa, and M. Kikuchi Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs Metabolism 51 2002 575 581
29. A. Okamura, A. Emoto, N. Koyabu, H. Ohtani, and Y. Sawada Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1 Br. J. Pharmacol. 137 2002 391 399
30. R.E. Pratley, and C. Weyer The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus Diabetologia 44 2001 929 945
31. Y. Sato, M. Nishikawa, H. Shinkai, and E. Sukegawa Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4- isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals Diabetes Res. Clin. Pract. 12 1991 53 59
32. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod Nitric oxide release accounts for insulin's vascular effects in humans J. Clin. Invest. 94 1994 2511 2515
33. S. Seino ATP-sensitive potassium channels. A model of heteromultimeric potassium channel/receptor assemblies Annu. Rev. Physiol. 61 1999 337 362
34. H. Shinkai, K. Toi, I. Kumashiro, Y. Seto, M. Fukuma, K. Dan, and S. Toyoshima N-acylphenylalanines and related compounds. A new class of oral hypoglycemic agents J. Med. Chem. 31 1988 2092 2097
35. S.R. Smukler, L. Tang, M.B. Wheeler, and A.M. Salapatek Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release Diabetes 51 2002 3450 3460
36. C. Suschek, K. Fehsel, K.D. Kroncke, A. Sommer, and V. Kolb-Bachofen Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophage-like nitric oxide synthases are expressed and activities regulated by glucose concentration Am. J. Pathol. 145 1994 685 695
37. A.M. Svensson, C.G. Östenson, S. Sandler, S. Efendic, and L. Jansson Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats Endocrinology 135 1994 849 853
38. A.M. Svensson, C.G. Östenson, and L. Jansson Age-induced changes in pancreatic islet blood flow. Evidence for an impaired regulation in diabetic GK rats Am. J. Physiol. 279 2000 E1139 E1144
39. F. Vetterlein, D. Senske, C. Bornkessel, and G. Schmidt Effects of tolbutamide on blood flow in islets and exocrine tissue of the rat pancreas Eur. J. Pharmacol. 113 1985 395 398